Jundishapur Journal of Microbiology

Published by: Kowsar

Higher Serum Levels of Type I Interferon Receptor in Adults with Chronic Hepatitis B Leading to Hepatitis B Surface Antigen Clearance

Ashraf Mohamadkhani 1 , Sima Besharat 2 , Golnosh Gol-Jah Rad 1 , Akbar Pour Dadash Asiabar 3 , Gholamreza Roshandel 2 , Akram Pourshams 1 and Hossein Poustchi 1 , *
Authors Information
1 Liver and Pancreatobiliary Diseases Research Center, Digestive Diseases Research Institute, Tehran University of Medical Sciences, Tehran, Iran
2 Golestan Research Center of Gastroentrology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran
3 Microbiology Laboratory, Dr. Shariati Hospital, Tehran, Iran
Article information
  • Jundishapur Journal of Microbiology: March 01, 2017, 10 (3); e41319
  • Published Online: February 1, 2017
  • Article Type: Research Article
  • Received: August 7, 2016
  • Revised: January 15, 2017
  • Accepted: January 23, 2017
  • DOI: 10.5812/jjm.41319

To Cite: Mohamadkhani A, Besharat S, Gol-Jah Rad G, Pour Dadash Asiabar A, Roshandel G, et al. Higher Serum Levels of Type I Interferon Receptor in Adults with Chronic Hepatitis B Leading to Hepatitis B Surface Antigen Clearance, Jundishapur J Microbiol. 2017 ; 10(3):e41319. doi: 10.5812/jjm.41319.

Abstract
Copyright © 2017, Ahvaz Jundishapur University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. Fattovich G, Brollo L, Giustina G, Noventa F, Pontisso P, Alberti A, et al. Natural history and prognostic factors for chronic hepatitis type B. Gut. 1991; 32(3): 294-8[PubMed]
  • 2. Nguyen T, Thompson AJ, Bowden S, Croagh C, Bell S, Desmond PV, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol. 2010; 52(4): 508-13[DOI][PubMed]
  • 3. McMahon BJ. Natural history of chronic hepatitis B - clinical implications. Medscape J Med. 2008; 10(4): 91[PubMed]
  • 4. Liaw YF, Sheen IS, Chen TJ, Chu CM, Pao CC. Incidence, determinants and significance of delayed clearance of serum HBsAg in chronic hepatitis B virus infection: a prospective study. Hepatology. 1991; 13(4): 627-31[DOI][PubMed]
  • 5. Yuen MF, Wong DK, Sablon E, Tse E, Ng IO, Yuan HJ, et al. HBsAg seroclearance in chronic hepatitis B in the Chinese: virological, histological, and clinical aspects. Hepatology. 2004; 39(6): 1694-701[DOI][PubMed]
  • 6. Moradzadeh M, Tayebi S, Poustchi H, Sayehmiri K, Shahnazari P, Naderi E, et al. The Possible Role of TLR2 in Chronic Hepatitis B Patients with Precore Mutation. Adv Virol. 2013; 2013: 780319[DOI][PubMed]
  • 7. Mohamadkhani A, Bastani F, Khorrami S, Ghanbari R, Eghtesad S, Sharafkhah M, et al. Negative Association of Plasma Levels of Vitamin D and miR-378 With Viral Load in Patients With Chronic Hepatitis B Infection. Hepat Mon. 2015; 15(6): 28315[DOI][PubMed]
  • 8. Bertoletti A, Gehring AJ. The immune response during hepatitis B virus infection. J Gen Virol. 2006; 87: 1439-49[DOI][PubMed]
  • 9. Swiecki M, Wang Y, Vermi W, Gilfillan S, Schreiber RD, Colonna M. Type I interferon negatively controls plasmacytoid dendritic cell numbers in vivo. J Exp Med. 2011; 208(12): 2367-74[DOI][PubMed]
  • 10. Lohr HF, Weber W, Schlaak J, Goergen B, Meyer zum Buschenfelde KH, Gerken G. Proliferative response of CD4+ T cells and hepatitis B virus clearance in chronic hepatitis with or without hepatitis B e-minus hepatitis B virus mutants. Hepatology. 1995; 22(1): 61-8[DOI][PubMed]
  • 11. Martinet J, Leroy V, Dufeu-Duchesne T, Larrat S, Richard MJ, Zoulim F, et al. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection. Hepatology. 2012; 56(5): 1706-18[DOI][PubMed]
  • 12. Duan XZ, Wang M, Li HW, Zhuang H, Xu D, Wang FS. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDC) in hepatitis B virus infected humans. J Clin Immunol. 2004; 24(6): 637-46[DOI][PubMed]
  • 13. Novick D, Cohen B, Rubinstein M. The human interferon alpha/beta receptor: characterization and molecular cloning. Cell. 1994; 77(3): 391-400[DOI][PubMed]
  • 14. Wei L, Bello AM, Majchrzak-Kita B, Salum N, Lewis MM, Kotra LP, et al. Small Molecule Agonists for the Type I Interferon Receptor: An In Silico Approach. J Interferon Cytokine Res. 2016; 36(3): 180-91[DOI][PubMed]
  • 15. Huang MT, Liu WL, Lu CW, Huang JJ, Chuang HL, Huang YT, et al. Feedback regulation of IFN-alpha/beta signaling by Axl receptor tyrosine kinase modulates HBV immunity. Eur J Immunol. 2015; 45(6): 1696-705[DOI][PubMed]
  • 16. Poustchi H, Katoonizadeh A, Ostovaneh MR, Moossavi S, Sharafkhah M, Esmaili S, et al. Cohort profile: golestan hepatitis B cohort study- a prospective long term study in northern iran. Middle East J Dig Dis. 2014; 6(4): 186-94[PubMed]
  • 17. Pourshams A, Khademi H, Malekshah AF, Islami F, Nouraei M, Sadjadi AR, et al. Cohort Profile: The Golestan Cohort Study--a prospective study of oesophageal cancer in northern Iran. Int J Epidemiol. 2010; 39(1): 52-9[DOI][PubMed]
  • 18. McMahon BJ. Hepatitis B surface antigen (HBsAg): a 40-year-old hepatitis B virus seromarker gets new life. Gastroenterology. 2010; 139(2): 380-2[DOI][PubMed]
  • 19. Mohamadkhani A, Montazeri G, Poustchi H. The importance of hepatitis B virus genome diversity in Basal core promoter region. Middle East J Dig Dis. 2011; 3(1): 13-9[PubMed]
  • 20. Mohamadkhani A, Katoonizadeh A, Poustchi H. Immune-Regulatory Events in the Clearance of HBsAg in Chronic Hepatitis B: Focuses on HLA-DP. Middle East J Dig Dis. 2015; 7(1): 5-13[PubMed]
  • 21. Besharat S, Katoonizadeh A, Moossavi S, Darvishi Z, Roshandel G, Poustchi H, et al. The possible impact of sortilin in reducing HBsAg expression in chronic hepatitis B. J Med Virol. 2016; 88(4): 647-52[DOI][PubMed]
  • 22. Tseng TC, Liu CJ, Su TH, Wang CC, Chen CL, Chen PJ, et al. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. Gastroenterology. 2011; 141(2): 517-25[DOI][PubMed]
  • 23. Mizukoshi E, Kaneko S, Kaji K, Terasaki S, Matsushita E, Muraguchi M, et al. Serum levels of soluble interferon Alfa/Beta receptor as an inhibitory factor of interferon in the patients with chronic hepatitis C. Hepatology. 1999; 30(5): 1325-31[DOI][PubMed]
  • 24. Zhao J, Fan YC, Sun FK, Zhao ZH, Wang LY, Hu LH, et al. Peripheral type I interferon receptor correlated with oxidative stress in chronic hepatitis B virus infection. J Interferon Cytokine Res. 2013; 33(8): 405-14[DOI][PubMed]
  • 25. Hardy MP, Owczarek CM, Trajanovska S, Liu X, Kola I, Hertzog PJ. The soluble murine type I interferon receptor Ifnar-2 is present in serum, is independently regulated, and has both agonistic and antagonistic properties. Blood. 2001; 97(2): 473-82[DOI][PubMed]
  • 26. Samarajiwa SA, Mangan NE, Hardy MP, Najdovska M, Dubach D, Braniff SJ, et al. Soluble IFN receptor potentiates in vivo type I IFN signaling and exacerbates TLR4-mediated septic shock. J Immunol. 2014; 192(9): 4425-35[DOI][PubMed]
  • 27. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science. 1999; 284(5415): 825-9[DOI][PubMed]
  • 28. Hertzog PJ, Wright A, Harris G, Linnane AW, Mackay IR. Intermittent interferonemia and interferon responses in multiple sclerosis. Clin Immunol Immunopathol. 1991; 58(1): 18-32[DOI][PubMed]
  • 29. Martinet J, Dufeu-Duchesne T, Bruder Costa J, Larrat S, Marlu A, Leroy V, et al. Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection. Gastroenterology. 2012; 143(6): 1586-96[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments